News & Blog

October 26, 2022 | Press Release
Multi-omics Startup Pleno Inc. Expands Leadership Team to Accelerate Development of its Novel Hypercoding Technology
October 19, 2022 | Press Release
CMC Expert Kim Raineri Joins Aspen Neuroscience as Chief Technology Officer
October 12, 2022 | Press Release
Multi-omics Startup Pleno Inc. Announces $40 Million in Series A Funding Led by Deerfield Management with Participation by Foresite Capital
October 05, 2022 | Press Release
Immunitas Therapeutics to Present Preclinical Data on IMT-009 at the 2022 Society for Immunotherapy of Cancer (SITC) Annual Meeting
September 21, 2022 | Press Release
Immunitas Therapeutics Receives FDA Clearance of IND Application for IMT-009 in Solid Tumors and Hematological Malignancies
August 23, 2022 | In The News
BioCentury: Medical Excellence to fund cell, gene therapy, AI and regenerative medicine with $145M debut fund
August 23, 2022 | In The News
Wall Street Journal: Life Sciences Venture Investor MEC Raises $145 Million Fund
August 23, 2022 | Press Release
Medical Excellence Capital Announces $145 Million Final Close for Inaugural Venture Fund
July 26, 2022 | Blog Post
Cell Therapy in CNS: Why now?
July 13, 2022 | Press Release
Immunitas Therapeutics Appoints Lynette Herscha as Chief Operating Officer